A powerful new software platform called the Playbook Workflow Builder is set to transform biomedical research by allowing ...

Trontinemab is currently being studied in the Phase Ib/IIa Brainshuttle AD study assessing the safety, tolerability, ...

Siemens AG has agreed to acquire Dotmatics for $5.1 billion as part of a push to provide more artificial intelligence ...